Go low or say No to aggressive systolic BP goals?
Metadata[+] Show full item record
"Go low" or say "No" to aggressive systolic BP goals? The SPRINT trial demonstrated the benefits -- and risks -- of reaching a systolic target <120 mm Hg in non-diabetic patients at high risk for CV events. Here's who might benefit. Practice changer: Consider treating non-diabetic patients age greater than or equal to 50 years to a systolic blood pressure (SBP) target <120 mm Hg as compared to <140 mm Hg when the benefits -- lower rates of fatal and nonfatal cardiovascular (CV) events and death from any cause -- are likely to outweigh the risks from possible additional medication.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.